tiprankstipranks
Leadership Transition at Carisma Therapeutics’ Board of Directors
Company Announcements

Leadership Transition at Carisma Therapeutics’ Board of Directors

Don't Miss our Black Friday Offers:

Carisma Therapeutics ( (CARM) ) just unveiled an update.

Michael Torok is stepping down from Carisma Therapeutics’ board of directors due to other professional commitments, making way for the appointment of Sohanya Cheng. Cheng will join the audit committee and receive a compensation package including cash and stock options, aligning with the company’s non-employee director compensation policy. Her appointment reflects a seamless transition in leadership, offering stability and continuity for the company’s governance.

For detailed information about CARM stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyCarisma Therapeutics reports data from its CAR-M therapy
TheFlyCarisma Therapeutics reports Q3 EPS (31c), consensus (26c)
TheFlyCarisma to present new data on CAR-M therapy for hepatocellular carcinoma
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App